348 related articles for article (PubMed ID: 32527304)
1. Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients.
Convertino I; Tuccori M; Ferraro S; Valdiserra G; Cappello E; Focosi D; Blandizzi C
Crit Care; 2020 Jun; 24(1):331. PubMed ID: 32527304
[TBL] [Abstract][Full Text] [Related]
2. Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
Cala-García JD; Sierra-Bretón JD; Cavelier-Baiz JE; Faccini-Martínez ÁA; Pérez-Díaz CE
Immunotherapy; 2020 Oct; 12(15):1127-1132. PubMed ID: 32664810
[No Abstract] [Full Text] [Related]
3. Physiological Changes During Prone Positioning in COVID-19 Acute Respiratory Distress Syndrome.
Lee RM; Tan GP; Puah SH; Ling LM; Choy CY; Chotirmall SH; Abisheganaden J; See JJ; Tan HL; Wong YL
Ann Acad Med Singap; 2020 Jul; 49(7):509-513. PubMed ID: 33000116
[No Abstract] [Full Text] [Related]
4. Regulatory T Cells Tested in Patients With COVID-19 ARDS.
Abbasi J
JAMA; 2020 Aug; 324(6):539. PubMed ID: 32780125
[No Abstract] [Full Text] [Related]
5. Oxygenation device with reservoir and PEEP (ODRPEEP) in patients with acute respiratory distress due to COVID-19.
Segura Alba O; Nieto Fernández-Pacheco A; Pardo Ríos M
Med Clin (Barc); 2020 Aug; 155(3):133-134. PubMed ID: 32482415
[No Abstract] [Full Text] [Related]
6. Fibrin-derived peptide Bβ15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome.
Adam EH; Schmid B; Sonntagbauer M; Kranke P; Zacharowski K; Meybohm P
Crit Care; 2020 Sep; 24(1):574. PubMed ID: 32972429
[No Abstract] [Full Text] [Related]
7. Lessons from an ICU recovery clinic: two cases of meralgia paresthetica after prone positioning to treat COVID-19-associated ARDS and modification of unit practices.
Bellinghausen AL; LaBuzetta JN; Chu F; Novelli F; Rodelo AR; Owens RL
Crit Care; 2020 Sep; 24(1):580. PubMed ID: 32981525
[No Abstract] [Full Text] [Related]
8. Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.
Matsumura K; Toyoda Y; Matsumoto S; Kawai Y; Mori T; Omasa K; Fukada T; Yamada M; Kazamaki T; Furugori S; Hiroe N; Senoo S; Shimizu M; Funabiki T; Yamazaki M
Am J Case Rep; 2020 Aug; 21():e926835. PubMed ID: 32811804
[TBL] [Abstract][Full Text] [Related]
9. Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology.
Wauters E; Thevissen K; Wouters C; Bosisio FM; De Smet F; Gunst J; Humblet-Baron S; Lambrechts D; Liston A; Matthys P; Neyts J; Proost P; Weynand B; Wauters J; Tejpar S; Garg AD
Front Immunol; 2020; 11():1642. PubMed ID: 32719686
[No Abstract] [Full Text] [Related]
10. Weathering the Cytokine Storm in COVID-19: Therapeutic Implications.
Iannaccone G; Scacciavillani R; Del Buono MG; Camilli M; Ronco C; Lavie CJ; Abbate A; Crea F; Massetti M; Aspromonte N
Cardiorenal Med; 2020; 10(5):277-287. PubMed ID: 32599589
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports.
Gladstone DE; Kim BS; Mooney K; Karaba AH; D'Alessio FR
Ann Intern Med; 2020 Nov; 173(10):852-853. PubMed ID: 32628535
[No Abstract] [Full Text] [Related]
12. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?
Fan E; Beitler JR; Brochard L; Calfee CS; Ferguson ND; Slutsky AS; Brodie D
Lancet Respir Med; 2020 Aug; 8(8):816-821. PubMed ID: 32645311
[TBL] [Abstract][Full Text] [Related]
13. Overview of Stem Cell Therapy for Acute Respiratory Distress Syndrome with Focus on COVID 19.
Kaye RJ
Pain Physician; 2020 Aug; 23(4S):S421-S432. PubMed ID: 32942797
[TBL] [Abstract][Full Text] [Related]
14. The ARDSnet protocol may be detrimental in COVID-19.
Tsolaki V; Zakynthinos GE; Makris D
Crit Care; 2020 Jun; 24(1):351. PubMed ID: 32546230
[No Abstract] [Full Text] [Related]
15. Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort?
Falcoz PE; Monnier A; Puyraveau M; Perrier S; Ludes PO; Olland A; Mertes PM; Schneider F; Helms J; Meziani F
Am J Respir Crit Care Med; 2020 Aug; 202(3):460-463. PubMed ID: 32543208
[No Abstract] [Full Text] [Related]
16. The Basics of ARDS Mechanical Ventilatory Care for Cardiovascular Specialists.
Rayner-Hartley E; Miller PE; Burstein B; Bibas L; Goldfarb M; Rampersad P; van Diepen S
Can J Cardiol; 2020 Oct; 36(10):1675-1679. PubMed ID: 32712309
[TBL] [Abstract][Full Text] [Related]
17. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment.
Wang XY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4537-4538. PubMed ID: 32373992
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).
Ma X; Liang M; Ding M; Liu W; Ma H; Zhou X; Ren H
Med Sci Monit; 2020 Aug; 26():e925364. PubMed ID: 32759887
[TBL] [Abstract][Full Text] [Related]
19. Successful management of the first reported case in Austria of COVID-19 with ARDS.
Seitz T; Hoepler W; Weseslindtner L; Aberle JH; Aberle SW; Puchhammer-Stoeckl E; Baumgartner S; Traugott M; Karolyi M; Pawelka E; Niculescu I; Friese E; Neuhold S; Stahl D; Madl C; Zoufaly A; Wenisch C; Laferl H
Infection; 2020 Aug; 48(4):647-651. PubMed ID: 32535876
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.
Alijotas-Reig J; Esteve-Valverde E; Belizna C; Selva-O'Callaghan A; Pardos-Gea J; Quintana A; Mekinian A; Anunciacion-Llunell A; Miró-Mur F
Autoimmun Rev; 2020 Jul; 19(7):102569. PubMed ID: 32376394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
